FDA Enforcement Class II Ongoing

RX Series Copper (Cu) Assay Ref. Number CU2340

Recall: Z-0992-2024 · Reported February 14, 2024

Enforcement

Recall Number
Z-0992-2024
Event ID
93775
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Randox Laboratories Ltd.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
February 14, 2024
Initiation Date
November 29, 2023
Classification Date
February 6, 2024
Address
55 Diamond Road, Crumlin (North), N/A, Ireland

Description

RX Series Copper (Cu) Assay Ref. Number CU2340

Reason

Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.

Code Info

Catalogue Number/GTIN: CU2340 05055273201949; Lot/batch: 592278, 610661, 610669, 629021, 647201, 657944;

Distribution

US Nationwide distribution in the states of SC and OK.

Quantity

3,053 kits (2 US, 3,051 OUS)